An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder.
D000293:Adolescent; D000928:Antidepressive Agents / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D002648:Child; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004562:Electrocardiography; D005260:Female; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D010349:Patient Compliance; D011437:Propylamines / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D011446:Prospective Studies; D011581:Psychological Tests; D012720:Severity of Illness Index